{"name":"Glaukos","permalink":"glaukos","crunchbase_url":"http://www.crunchbase.com/company/glaukos","homepage_url":"http://www.glaukos.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":null,"number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"contact@glaukos.com","phone_number":"949-367-9600","description":"","created_at":"Tue Jun 23 02:48:01 UTC 2009","updated_at":"Thu Feb 03 07:01:17 UTC 2011","overview":"<p>Glaukos Corporation is committed to transforming glaucoma therapy.\nTo this end, Glaukos is bypassing anatomical impediments and treatment conventions to develop treatments that restore natural physiologic outflow as a foundation of significant, steady and sustained glaucoma management. Today, they are at the beginning with an innovative micro technology. In collaboration with their clinician partners, they are building technology towards a safer and more effective treatment for preserving vision in patients with primary open-angle glaucoma.</p>","image":{"available_sizes":[[[135,22],"assets/images/resized/0005/0243/50243v1-max-150x150.png"],[[135,22],"assets/images/resized/0005/0243/50243v1-max-250x250.png"],[[135,22],"assets/images/resized/0005/0243/50243v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Board Observer","person":{"first_name":"Paul","last_name":"Madera","permalink":"paul-madera","image":{"available_sizes":[[[117,150],"assets/images/resized/0004/4662/44662v1-max-150x150.jpg"],[[150,192],"assets/images/resized/0004/4662/44662v1-max-250x250.jpg"],[[150,192],"assets/images/resized/0004/4662/44662v1-max-450x450.jpg"]],"attribution":"<p>Meritech Capital</p>"}}}],"competitions":[],"providerships":[],"total_money_raised":"$64.5M","funding_rounds":[{"round_code":"d","source_url":"http://www.equityhelpdesk.com/PrivateEquity/Glaukos_Adds_35_Million","source_description":"Glaukos Adds $35 Million","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":29,"investments":[{"company":null,"financial_org":{"name":"OrbiMed Advisors","permalink":"orbimed-advisors","image":{"available_sizes":[[[150,42],"assets/images/resized/0005/0248/50248v1-max-150x150.png"],[[203,58],"assets/images/resized/0005/0248/50248v1-max-250x250.png"],[[203,58],"assets/images/resized/0005/0248/50248v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Frazier Healthcare Ventures","permalink":"frazier-healthcare-ventures","image":{"available_sizes":[[[150,70],"assets/images/resized/0003/2779/32779v1-max-150x150.png"],[[153,72],"assets/images/resized/0003/2779/32779v1-max-250x250.png"],[[153,72],"assets/images/resized/0003/2779/32779v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"InterWest Partners","permalink":"interwest-partners","image":{"available_sizes":[[[117,56],"assets/images/resized/0002/9316/29316v1-max-150x150.png"],[[117,56],"assets/images/resized/0002/9316/29316v1-max-250x250.png"],[[117,56],"assets/images/resized/0002/9316/29316v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Domain Associates","permalink":"domain-associates","image":{"available_sizes":[[[150,72],"assets/images/resized/0003/2807/32807v1-max-150x150.png"],[[250,121],"assets/images/resized/0003/2807/32807v1-max-250x250.png"],[[264,128],"assets/images/resized/0003/2807/32807v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Fjord Ventures","permalink":"fjord-ventures","image":{"available_sizes":[[[140,125],"assets/images/resized/0005/0251/50251v1-max-150x150.png"],[[140,125],"assets/images/resized/0005/0251/50251v1-max-250x250.png"],[[140,125],"assets/images/resized/0005/0251/50251v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Montreux Equity Partners","permalink":"montreaux-equity-partners","image":{"available_sizes":[[[150,44],"assets/images/resized/0005/0252/50252v1-max-150x150.png"],[[194,57],"assets/images/resized/0005/0252/50252v1-max-250x250.png"],[[194,57],"assets/images/resized/0005/0252/50252v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Versant Ventures","permalink":"versant-ventures","image":{"available_sizes":[[[150,90],"assets/images/resized/0004/6455/46455v1-max-150x150.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-250x250.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"e","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020110203e72300004&r=Rss&s=DJFVLS","source_description":"Glaukos Sees $29.5M Series E Round For Tiny Eye Device  ","raised_amount":29500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":2,"investments":[]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"26051 Merit Circle","address2":"Suite 103","zip_code":"92653 ","city":"Laguna Hills","state_code":"CA","country_code":"USA","latitude":33.574055,"longitude":-117.6749073}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,123],"assets/images/resized/0005/0244/50244v1-max-150x150.jpg"],[[250,205],"assets/images/resized/0005/0244/50244v1-max-250x250.jpg"],[[450,369],"assets/images/resized/0005/0244/50244v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}